000 01012 a2200289 4500
005 20250516025840.0
264 0 _c20120106
008 201201s 0 0 eng d
022 _a1522-9645
024 7 _a10.1093/eurheartj/ehr044
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGheorghiade, Mihai
245 0 0 _aBeyond dyspnoea as an endpoint in acute heart failure trials.
_h[electronic resource]
260 _bEuropean heart journal
_cJun 2011
300 _a1442-5 p.
_bdigital
500 _aPublication Type: Editorial; Comment
650 0 4 _aAdenosine A1 Receptor Antagonists
_xadministration & dosage
650 0 4 _aDyspnea
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHeart Failure
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aXanthines
_xadministration & dosage
700 1 _aRuschitzka, Frank
773 0 _tEuropean heart journal
_gvol. 32
_gno. 12
_gp. 1442-5
856 4 0 _uhttps://doi.org/10.1093/eurheartj/ehr044
_zAvailable from publisher's website
999 _c20661330
_d20661330